PROC News and Press, Procaps Group S.A. From 11/16/22

Procaps Group, S.A. (PROC) Q3 2022 Earnings Conference Call November 16, 2022, 04:00 PM ET Company Participants Melissa Angelini - IR, Director Ruben Minski - Founder, Chief Executive Officer and Director Patricio Vargas - Chief Financial Officer Conference...

The following slide deck was published by Procaps Group S.A. in conjunction with their 2022 Q3 earnings call. For further details see: Procaps Group S.A. 2022 Q3 - Results - Earnings Call Presentation

MIAMI and BARRANQUILLA, Colombia, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Procaps Group S.A. (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced its financial results for the three months ended September 30, 2022 (ȁ...

MIAMI and BARRANQUILLA, Colombia, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced that it expects to report its results for the third quarter ended September 30, 2022, ...

MIAMI and BARRANQUILLA, Colombia, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced the completion of its inaugural 2021 ESG Annual Report, a comprehensive overview...

MIAMI and BARRANQUILLA, Colombia, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced it will participate in the BTG Pactual LatAm CEO Conference being held at the In...

Procaps Group press release ( NASDAQ: PROC ): Q2 Adj. EBITDA of $28M Revenue of $112M (+12.0% Y/Y) misses by $0.2M . For further details see: Procaps Group reports Q2 results

Net Revenues Increased 14% year-over-year in the Second Quarter, with Adjusted EBITDA Margin of 24% Constant currency Net Revenues Increased by 18% year-over-year in the First Half, signaling a strong demand across our businesses MIAMI and BARRANQUILLA, Colombia, Aug. 30, 2022...

Procaps Group (NASDAQ:PROC) has reported prelim Q1 net revenue of $86M (+11% Y/Y) vs. $86.70M consensus and adj. EBITDA of $9M (+15% Y/Y). The revenue growth was primarily driven by positive performances in the Procaps Colombia ( net revenue up 17.4% Y/Y), Central America North (+35.1% Y/Y re...

MIAMI and BARRANQUILLA, Colombia, June 02, 2022 (GLOBE NEWSWIRE) -- Procaps Group S.A. (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced its preliminary financial results for the quarter ended March 31, 2022 (&#x...